A Single-Center,Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle

Clinical trial NCT01685242 · COMPLETED

Trial details

NCT number: NCT01685242
Sponsor: Aciex Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Allergic Conjunctivitis

Start date: 2012-09-01
Primary completion: 2012-11-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.